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Abstract
Despite of the steady decrease of surgical site infection (SSI) over the last two decades, the incidence of SSI after
hip and knee arthroplasty has recently surged. This may be explained by technical changes that may result in an
increased risk of SSI, such as the broad implementation of fast track programs, and/or early interventions on
suspected SSI. By definition, early intervention may lead to a higher SSI score, even in the absence of a true SSI.
In any case, the reverse trend of SSI warrants further investigations.
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Over the last two decades it has been shown, that vari-
ous infection control measures are able to decrease the
rate of surgical site infection (SSI) for total hip and knee
arthroplasty (THA/TKA) [1-3]. In the Netherlands, the
incidence of SSI after THA/TKA fell from 3% to 1.5%
during the early years of the present millennium [4] and
seemed to have levelled out at 1-2% during the last
years, according to the Dutch national surveillance
system for healthcare-associated infections (PREZIES).
Most recently, and despite the above mentioned consist-
ent national trend, the Dutch Health Care Inspectorate
(IGZ) received reports from a significant number of
orthopaedic surgery departments, that their rates of SSI
after THA/TKA rose to more than 2%, which is presently
seen as the acceptable upper limit of SSI-rate for this type
of surgery. While an incidental, temporary increase in any
kind of SSI rate may be explained by local circumstances,
the reverse trend in national incidence rates for multiple
centres demands further investigations.
What were the changes in the pre-, peri-, and post-
operative procedures with regard to THA and TKA? Most
importantly, which of those changes were implemented
on a (close to) national level, in order to achieve the ob-
served effect? We believe that two major practice changes
might be responsible for the recent changes, or at least a
major part of it: “fast-track” and “early intervention”.
The recent introduction of fast-track programs in THA
and TKA has attracted increasing appreciation in promot-
ing functional restoration, minimising co-morbidities and
shortening the duration of hospital stay [5,6]. However,
the question remains: has the implementation of appar-
ently successful fast-track orthopaedic surgery been com-
promised by higher risk of infections? The length of stay
for fast-track cohorts can be as short as two days as com-
pared with the conventional (up to) seven days [5]. Un-
doubtedly, this shortened hospitalisation period can
lighten the healthcare burden and increase patient satis-
faction. However, the early mobilisation as well as the
changes in the number of drains that are placed, or better
not placed, may result in suture dehiscence and/or in-
creased wound leakage which by consequence, may in-
crease the risk of SSI.
In addition, fall injury appears to be rather common
during the first week after fast track THA/ TKA, attrib-
utable to 25% of the fall incidences [7], which might
otherwise be preventable if the patient remained hospi-
talised. Therefore, early discharge from fast-track arthro-
plasty may increase risk for fall injury, which may
thereby disrupt newly closed surgical wounds, contribut-
ing to subsequent infection. In a recent Danish case–
control study, patients undergoing fast-track THA/ TKA
were found to have 30% increased risk for infection,
although the origins of the infection foci were not
comprehensively described [6]. This study compared
17,284 fast track arthroplasties with 61,814 conventional
arthroplasties in 2005 – 2011. Whilst the fast track co-
hort had a 30% reduced risk for thromboembolic event
and similar risk for re-operation and mortality, this
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group exhibited a significantly higher risk of re-admission
due to infection (RR = 1.3, 95% CI: 1.1 – 1.6). Although
the risk ratio appeared to be small, the authors noted that
a number of hospitals included in the national cohort had,
to some extent, implemented fast track program, albeit
not as systematically and/ or consistently as fast track par-
ticipanting institutes.
SSI is a consequence of multifactorial risk factors, in-
cluding pre-existing medical conditions and demograph-
ics [8]. Whether fast-track programs for THA/TKA
poses a higher risk for SSI needs to be clarified. Future
investigations should certainly look into components of
fast-track surgery, such as changes in the number and
placement of drains and early mobilisation and try to
evaluate their influence against the changes with regard
to the increasing presence of other risk-factors, such as
obesity, diabetes mellitus, and others.
In addition, the recent surge of SSI incidence may – in
part - be explained by early interventions on suspected
cases of SSI after arthroplasty [9]. When SSI is suspected
or persistent wound leakage is present, orthopaedic
surgeons can either wait and see, with or without anti-
biotic coverage, or explore the surgical wound. This is
frequently accompanied by placing a drain in an attempt
to remove any wound leakage. According to the current
surveillance guidelines (PREZIES), SSI is defined as the
presence of signs of local inflammation detected within
one year after arthroplasties, accompanying with purulent
drainage from incision, wound dishescence or wound
opened by surgeons. Therefore, the placement of a drain
in the surgical wound has already fulfilled one of the cri-
teria of defining SSI regardless of the bacterial culture re-
sults. This may lead to a “pseudo” increase in SSI, since
we believe that the surgeons trend to explore the wound
at an earlier time, than they used to. While early interven-
tions may be crucial in the final outcome of the patient
(implant retention), they may negatively influence the
SSI-rate. Consequently, we suggest including additional
outcome indicators such as implant retention after e.g.
two years to exclude “pseudo” SSI.
In summary, whether the recent increase in SSI inci-
dence in multiple Dutch hospitals is a consequence of
introduction of novel techniques such as “fast-tract pro-
grams” or an apparent “pseudo” increase in SSI incidence
as a result of a change of treatment strategies such as
“early interventions” remains to be elucidated.
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